FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Amanda Emmett

Research Profile

Chemicals & Drugs

Disorders

Asthma

Procedures

Phenomena

Concepts & Ideas

Devices

Nebulizers and Vaporizers

Co-author Network

Publications

TOP 3
Bradley E Chipps; Joseph D Spahn; Christine A Sorkness; Leslie Baitinger; Laura B Sutton; Amanda Emmett; Paul Dorinsky
Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting beta2-agonists.
Rohit Borker; Amanda Emmett; Priti Jhingran; Kathleen A Rickard; Paul Dorinsky
Determining economic feasibility of fluticasone propionate-salmeterol vs montelukast in the treatment of persistent asthma using a net benefit approach and cost-effectiveness acceptability curves.
Barry Make; Nicola A Hanania; Richard ZuWallack; Christopher Kalberg; Amanda Emmett; Christy P Brown; Katharine Knobil
The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Amanda Emmett (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Bradley E Chipps; Joseph D Spahn; Christine A Sorkness; Leslie Baitinger; Laura B Sutton; Amanda Emmett; Paul Dorinsky
Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting beta2-agonists.
The Journal of pediatrics 2006;148(4):517-21.
2005: Rohit Borker; Amanda Emmett; Priti Jhingran; Kathleen A Rickard; Paul Dorinsky
Determining economic feasibility of fluticasone propionate-salmeterol vs montelukast in the treatment of persistent asthma using a net benefit approach and cost-effectiveness acceptability curves.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2005;95(2):181-9.
2005: Barry Make; Nicola A Hanania; Richard ZuWallack; Christopher Kalberg; Amanda Emmett; Christy P Brown; Katharine Knobil
The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study.
Clinical therapeutics 2005;27(5):531-42.
2005: John M Weiler; Robert A Nathan; Ned T Rupp; Christopher Kalberg; Amanda Emmett; Paul Dorinsky
Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2005;94(1):65-72.
2005: Nicola A Hanania; Christopher Kalberg; J Yates; Amanda Emmett; Donald Horstman; Katharine Knobil
The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD.
Pulmonary pharmacology & therapeutics 2005;18(1):19-22.
2004: Elizabeth F Juniper; M E Wisniewski; FM Cox; Amanda Emmett; K E Nielsen; Paul M O'Byrne
Relationship between quality of life and clinical status in asthma: a factor analysis.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2004;23(2):287-91.
2004: Richard D O'Connor; Harold Nelson; Rohit Borker; Amanda Emmett; Priti Jhingran; Kathleen A Rickard; Paul Dorinsky
Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
PharmacoEconomics 2004;22(12):815-25.
2004: James F Donohue; Christopher Kalberg; Amanda Emmett; Kunal Merchant; Katharine Knobil
A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.
Treatments in respiratory medicine 2004;3(3):173-81.
2003: William J Calhoun; Laura B Sutton; Amanda Emmett; Paul Dorinsky
Asthma variability in patients previously treated with beta2-agonists alone.
The Journal of allergy and clinical immunology 2003;112(6):1088-94.
2002: David S Pearlman; Martha V White; Allen K Lieberman; Pamela J Pepsin; Christopher Kalberg; Amanda Emmett; Brian Bowers; Kathleen A Rickard; Paul Dorinsky
Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2002;88(2):227-35.
2002: Ketan Sheth; Rohit Borker; Amanda Emmett; Kathleen A Rickard; Paul Dorinsky
Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
PharmacoEconomics 2002;20(13):909-18.
2001: William J Calhoun; Harold S Nelson; Robert A Nathan; Pamela J Pepsin; Christopher Kalberg; Amanda Emmett; Kathleen A Rickard; Paul Dorinsky
Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone.
American journal of respiratory and critical care medicine 2001;164(5):759-63.
2001: J E Fish; E Israel; John Joseph Murray; Amanda Emmett; R Boone; Steven W Yancey; Kathleen A Rickard
Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
Chest 2001;120(2):423-30.
2001: Richard ZuWallack; Donald A Mahler; D Reilly; NL Church; Amanda Emmett; Kathleen A Rickard; Katharine Knobil
Salmeterol plus theophylline combination therapy in the treatment of COPD.
Chest 2001;119(6):1661-70.
2001: J Matz; Amanda Emmett; Kathleen A Rickard; Christopher Kalberg
Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations.
The Journal of allergy and clinical immunology 2001;107(5):783-9.
2000: Harold S Nelson; William W Busse; Edward M Kerwin; NL Church; Amanda Emmett; Kathleen A Rickard; Katharine Knobil
Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
The Journal of allergy and clinical immunology 2000;106(6):1088-95.
1999: Steven G Kelsen; NL Church; S A Gillman; B Q Lanier; Amanda Emmett; Kathleen A Rickard; Wayne H Anderson
Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial.
The Journal of asthma : official journal of the Association for the Care of Asthma 1999;36(8):703-15.
1999: Richard R. Rosenthal; William W Busse; J P Kemp; J W Baker; Christopher Kalberg; Amanda Emmett; Kathleen A Rickard
Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Chest 1999;116(3):595-602.
1999: Robert A Nathan; J L Pinnas; HJ Schwartz; J Grossman; Steven W Yancey; Amanda Emmett; Kathleen A Rickard
A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 1999;82(6):521-9.
1999: John Joseph Murray; NL Church; Wayne H Anderson; D I Bernstein; S E Wenzel; Amanda Emmett; Kathleen A Rickard
Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases.
Allergy and asthma proceedings : the official journal of regional and state allergy societies 1999;20(3):173-80.
1999: Harold S Nelson; R B Berkowitz; D A Tinkelman; Amanda Emmett; Kathleen A Rickard; Steven W Yancey
Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma.
American journal of respiratory and critical care medicine 1999;159(5 Pt 1):1556-61.
1999: J J Condemi; S Goldstein; Christopher Kalberg; Steven W Yancey; Amanda Emmett; Kathleen A Rickard
The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 1999;82(4):383-9.
1998: S E Wenzel; W Lumry; M Manning; Christopher Kalberg; FM Cox; Amanda Emmett; Kathleen A Rickard
Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 1998;80(6):463-70.
1998: J P Kemp; D A Cook; G A Incaudo; J Corren; Christopher Kalberg; Amanda Emmett; FM Cox; Kathleen A Rickard
Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.
The Journal of allergy and clinical immunology 1998;101(2 Pt 1):188-95.
1997: S J Pollard; S L Spector; Steven W Yancey; FM Cox; Amanda Emmett
Salmeterol versus theophylline in the treatment of asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 1997;78(5):457-64.